Thus, studies of MSMD have revealed that human antimycobacterial immunity is a genetically controlled quantitative trait: the lower the level of IFN-γ activity, the more severe the disease and the higher its penetrance16. This evidence concerns the gene IFNG and Mendelian susceptibility to mycobacterial diseases.